Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

2.

Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.

Siegmund K, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, Schmidt-Weber CB.

J Immunol. 2009 Feb 15;182(4):2124-30. doi: 10.4049/jimmunol.0802271.

3.

Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.

Mahic M, Henjum K, Yaqub S, Bjørnbeth BA, Torgersen KM, Taskén K, Aandahl EM.

Eur J Immunol. 2008 Mar;38(3):640-6. doi: 10.1002/eji.200737529.

5.

Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.

Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, Renaudineau S, Achachi A, Benetiere J, Kaiserlian D, Dubois B, Nicolas JF.

J Allergy Clin Immunol. 2010 Aug;126(2):280-9, 289.e1-7. doi: 10.1016/j.jaci.2010.05.022. Epub 2010 Jul 10.

PMID:
20624644
6.

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Lim A, French MA, Price P.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57. doi: 10.1097/QAI.0b013e3181a74fad.

PMID:
19363449
7.

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M, Pircher H, Di Nicola M, Mortarini R.

Cancer Res. 2010 Nov 1;70(21):8378-87. doi: 10.1158/0008-5472.CAN-10-2028. Epub 2010 Sep 21.

8.

CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.

Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, Sparwasser T.

Eur J Immunol. 2011 Mar;41(3):716-25. doi: 10.1002/eji.201040913. Epub 2011 Feb 11.

9.

Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.

Fenoglio D, Ferrera F, Fravega M, Balestra P, Battaglia F, Proietti M, Andrei C, Olive D, Antonio LC, Indiveri F, Filaci G.

Hum Immunol. 2008 Nov;69(11):745-50. doi: 10.1016/j.humimm.2008.08.282. Epub 2008 Sep 29.

PMID:
18832002
10.

Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.

Scotto L, Naiyer AJ, Galluzzo S, Rossi P, Manavalan JS, Kim-Schulze S, Fang J, Favera RD, Cortesini R, Suciu-Foca N.

Hum Immunol. 2004 Nov;65(11):1297-306.

PMID:
15556680
11.

Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.

Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U.

Eur J Immunol. 2006 Oct;36(10):2658-70.

12.

Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function.

Jarvis LB, Matyszak MK, Duggleby RC, Goodall JC, Hall FC, Gaston JS.

Eur J Immunol. 2005 Oct;35(10):2896-908.

13.

Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines.

Xie D, Hai B, Xie X, Liu L, Ayello J, Ma X, Zhang J.

Cell Immunol. 2009;259(2):157-64. doi: 10.1016/j.cellimm.2009.06.011. Epub 2009 Jun 23.

PMID:
19616200
14.

FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.

Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.

Gastroenterology. 2009 Oct;137(4):1280-8.e1-6. doi: 10.1053/j.gastro.2009.06.059. Epub 2009 Jul 29.

PMID:
19596013
15.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
16.

Influenza matrix 1-specific human CD4+ FOXP3+ and FOXP3(-) regulatory T cells can be detected long after viral clearance.

Piersma SJ, van der Hulst JM, Kwappenberg KM, Goedemans R, van der Minne CE, van der Burg SH.

Eur J Immunol. 2010 Nov;40(11):3064-74. doi: 10.1002/eji.200940177. Epub 2010 Sep 6.

17.

Chronic antigen stimulation in vivo induces a distinct population of antigen-specific Foxp3 CD25 regulatory T cells.

Hansen W, Westendorf AM, Reinwald S, Bruder D, Deppenmeier S, Groebe L, Probst-Kepper M, Gruber AD, Geffers R, Buer J.

J Immunol. 2007 Dec 15;179(12):8059-68. Erratum in: J Immunol. 2008 Oct 15;181(8):5803.

18.

Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.

Jacobo P, Guazzone VA, Jarazo-Dietrich S, Theas MS, Lustig L.

J Reprod Immunol. 2009 Jul;81(1):44-54. doi: 10.1016/j.jri.2009.04.005. Epub 2009 Jun 10.

PMID:
19520436
19.

Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35.

Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Herminé A, Devergne O.

J Immunol. 2008 Nov 15;181(10):6898-905.

20.

Supplemental Content

Support Center